Skip to main content
. 2017 May 6;389(10081):1809–1820. doi: 10.1016/S0140-6736(17)30823-1

Figure 2.

Figure 2

Trial profile

Intention-to-treat analysis included all participants who were randomly assigned and received study medication (placebo or MLE4901; n=37). Per-protocol analysis included all participants who appropriately completed both treatment periods (n=28). See the appendix (pp 1–3) for more details about inclusion and exclusion criteria, and the number of participants affected by each.